Skip to Content

ZA 66 125 mg (Divalproex Sodium Delayed-Release (Sprinkle) 125 mg)

Pill with imprint ZA 66 125 mg is Blue & White, Capsule-shape and has been identified as Divalproex Sodium Delayed-Release (Sprinkle) 125 mg. It is supplied by Zydus Pharmaceuticals.

Divalproex sodium is used in the treatment of bipolar disorder; mania; epilepsy; migraine prevention and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 125 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for ZA 66 125 mg

Divalproex Sodium Delayed-Release (Sprinkle)

Imprint
ZA 66 125 mg
Strength
125 mg
Color
Blue & White
Size
22.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Fatty acid derivative anticonvulsants
Pregnancy Category
D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder, X - Not for use in pregnancy - When treating migraine
CSA Schedule
Not a controlled drug
Labeler / Supplier
Zydus Pharmaceuticals
Inactive Ingredients
alcohol, ammonia, butyl alcohol, microcrystalline cellulose, FD&C Blue No. 1, ferrosoferric oxide, gelatin, hypromelloses, isopropyl alcohol, methacrylic acid, potassium hydroxide, propylene glycol, shellac, silicon dioxide, sodium lauryl sulfate, magnesium silicate, titanium dioxide, triethyl citrate, water

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
68382-0106 Zydus Pharmaceuticals (USA) Inc.
68084-0313 Amerisource Health Services

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.